Ignite Creation Date:
2024-05-06 @ 1:26 PM
Last Modification Date:
2024-10-26 @ 1:14 PM
Study NCT ID:
NCT04027127
Status:
COMPLETED
Last Update Posted:
2019-07-19
First Post:
2019-06-18
Brief Title:
The Role of Netrin -1 in Acute Coronary Syndrome
Sponsor:
Aksaray University Training and Research Hospital
Organization:
Aksaray University Training and Research Hospital
Study Overview
Official Title:
The Effect of Serum Netrin-1 Levels on Diagnosis and Prognosis in Patients Presenting to the Emergency Department With Acute Coronary Syndrome
Status:
COMPLETED
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ACS-NETRİN-1
Brief Summary:
In our study Netrin -1 We found that patients with ACS increased at the time of admission decreased TIMI 3 flow after angiography and higher risk groups in high risk groups such as TIMI and GRACE were found to have higher Netrin-1 levels
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None